Takuji Hayashi

13PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemCancer geneticsMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Aug 24, 2026
Prognostic significance of the FAN score in patients with advanced urothelial carcinoma treated with enfortumab vedotin monotherapy.

|Jul 31, 2026
[18F]PSMA-1007 PET-Based Recurrence Site Distribution and Predictors of Metastatic Disease in Patients With Biochemical Recurrence of Prostate Cancer.

|Jul 20, 2026
Short-term efficacy and safety of enfortumab vedotin plus pembrolizumab as a first-line treatment for advanced urothelial carcinoma regardless of cisplatin eligibility.

|Jun 08, 2026
Adrenal Primary Ganglioneuroblastoma Presenting in Adulthood: A Case Report.

|Dec 12, 2025
Real-World Comparison of Survival Outcomes Between Radical Cystectomy and Intravesical Bacillus Calmette-Guérin (BCG) Therapy in BCG-Naïve or -Unresponsive Non-Muscle-Invasive Bladder Cancer.

Makito Miyake, Nobutaka Nishimura, Rikiya Taoka

|Dec 24, 2024
Risk assessment of late biochemical recurrence after radical prostatectomy: Usefulness of ultra-sensitive prostate-specific antigen measurement.

Norihiko Kawamura, Masashi Nakayama, Takuji Hayashi

Pageof 3

Frequent Collaborators

5 joint publications

Atsunari Kawashima

3 joint publications

Kazutoshi Fujita

3 joint publications

Yoshiyuki Yamamoto

2 joint publications

Yoichi Kakuta